临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2015年
24期
26-27
,共2页
糖尿病%肺炎%老年人%氨溴索%治疗结果
糖尿病%肺炎%老年人%氨溴索%治療結果
당뇨병%폐염%노년인%안추색%치료결과
Diabetes mellitus%Pneumonia%aged%Ambroxol%Treatment outcome
目的:探讨盐酸氨溴索联合头孢哌酮钠舒巴坦钠治疗老年糖尿病合并肺炎的临床疗效以及成本-效果。方法选择2012年1月—2013年4月遵义县人民医院收治的180例老年糖尿病合并肺炎患者,随机分为试验组和对照组,各90例。两组患者均给予基础治疗,试验组给予盐酸氨溴索联合头孢哌酮钠舒巴坦钠治疗,对照组给予盐酸溴己新片联合头孢哌酮钠舒巴坦钠治疗。比较两组患者的临床疗效及成本-效果。结果试验组总有效率为91.11%,高于对照组的61.11%,差异有统计学意义(P ﹤0.05);试验组的成本-效果比为29.61,低于对照组的32.38,差异有统计学意义(P ﹤0.05)。结论盐酸氨溴索联合头孢哌酮钠舒巴坦钠治疗老年糖尿病合并肺炎的临床疗效确切,成本-效果好。
目的:探討鹽痠氨溴索聯閤頭孢哌酮鈉舒巴坦鈉治療老年糖尿病閤併肺炎的臨床療效以及成本-效果。方法選擇2012年1月—2013年4月遵義縣人民醫院收治的180例老年糖尿病閤併肺炎患者,隨機分為試驗組和對照組,各90例。兩組患者均給予基礎治療,試驗組給予鹽痠氨溴索聯閤頭孢哌酮鈉舒巴坦鈉治療,對照組給予鹽痠溴己新片聯閤頭孢哌酮鈉舒巴坦鈉治療。比較兩組患者的臨床療效及成本-效果。結果試驗組總有效率為91.11%,高于對照組的61.11%,差異有統計學意義(P ﹤0.05);試驗組的成本-效果比為29.61,低于對照組的32.38,差異有統計學意義(P ﹤0.05)。結論鹽痠氨溴索聯閤頭孢哌酮鈉舒巴坦鈉治療老年糖尿病閤併肺炎的臨床療效確切,成本-效果好。
목적:탐토염산안추색연합두포고동납서파탄납치료노년당뇨병합병폐염적림상료효이급성본-효과。방법선택2012년1월—2013년4월준의현인민의원수치적180례노년당뇨병합병폐염환자,수궤분위시험조화대조조,각90례。량조환자균급여기출치료,시험조급여염산안추색연합두포고동납서파탄납치료,대조조급여염산추기신편연합두포고동납서파탄납치료。비교량조환자적림상료효급성본-효과。결과시험조총유효솔위91.11%,고우대조조적61.11%,차이유통계학의의(P ﹤0.05);시험조적성본-효과비위29.61,저우대조조적32.38,차이유통계학의의(P ﹤0.05)。결론염산안추색연합두포고동납서파탄납치료노년당뇨병합병폐염적림상료효학절,성본-효과호。
Objective To study the clinical efficacy and cost - effectiveness of ambroxol hydrochloride combined with cefoperazone - sulbactam sodium in the treatment of elderly diabetes mellitus and pneumonia. Methods From January 2012 to April 2013 in the People's Hospital of Zunyi County,a tatal of 180 elderly diabetes mellitus and pneumonia patients were select-ed and randomly divided into experiment group and control group,90 cases in each group. Two groups were all given basic treat-ment,the experiment group were treated with ambroxol hydrochloride combined with cefoperazone - sulbactam sodium,the con-trol group were treated with bromhexine hydrochloride tablets combined with cefoperazone - sulbactam sodium. Clinical efficacy and cost - effectiveness between the two groups were compared. Results The total effective rate of the experiment group was 91. 11% ,which was higher than 61. 11% of the control group,the difference was statistically significant(P ﹤ 0. 05);the cost- effectiveness ratio of the experiment group was 29. 61,which was lower than 32. 38 of the control group,the difference was statistically significant(P ﹤ 0. 05). Conclusion The clinical efficacy of ambroxol hydrochloride combined with cefoperazone -sulbactam sodium is sure in the treatment of elderly diabetes mellitus and pneumonia,cost - effectiveness is good.